QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

Connect Biopharma (CNTB) SEC Filings & 10K Form

$1.15
0.00 (0.00%)
(As of 02/21/2024 ET)

Recent Connect Biopharma SEC Filings

DateFilerForm TypeView
02/13/2024
3:18 PM
Connect Biopharma (Subject)
Wei Zheng (Filed by)
Form SC 13G/A
12/20/2023
3:30 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
12/18/2023
5:44 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
5:09 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
3:30 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
12/12/2023
6:40 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
6:05 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:10 AM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2023
4:20 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
11/27/2023
6:32 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
6:49 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
5:58 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
6:09 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
5:13 AM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/20/2023
3:44 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2023
4:26 PM
Connect Biopharma (Subject)
Huang James (Filed by)
Form SC 13G/A
09/12/2023
3:47 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2023
5:13 AM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2023
4:00 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2023
3:31 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
3:24 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2023
3:58 PM
Connect Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/11/2023
4:00 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CNTB) was last updated on 2/21/2024 by MarketBeat.com Staff